Funding
Funding opportunities for telehealth and broadband related programs.
Expiring in 1 month
| Title | Eligibility | Deadline | Learn More |
|---|---|---|---|
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) - This funding opportunity aims to support the development of cancer technologies for use in low- and middle-income countries (LMICs). The focus is on adapting and validating existing or emerging technologies to create user-friendly, cost-effective solutions for preventing, detecting, diagnosing, and treating cancers in LMIC populations, including the use of telehealth. | U.S. organizations, both private and public |
NIH | |
| Clinical, Behavioral, and Physiological Studies of Open- and Closed-loop Platforms: Toward Personalized, Fully Automated, Accessible Systems (R01 Clinical Trial Required) - This funding opportunity aims to support clinical research focused on technologies for physiological pancreatic hormone replacement open- and closed-loop systems. | U.S. organizations, both private and public |
NIH |
Expiring in 3 months
| Title | Eligibility | Deadline | Learn More |
|---|---|---|---|
| Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 – Clinical Trial Not Allowed) - This funding opportunity aims to support Clinical Centers of Excellence (DCoEs) in offering advanced diagnostic services for undiagnosed diseases nationwide. | U.S. organizations, both private and public |
NIH | |
| Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders Diagnosis and Treatment (R41/R42 Clinical Trial Optional) - This funding opportunity aims to lower the barriers for patients seeking access to substance use disorder (SUD) diagnosis and treatment. The focus is developing innovative, point-of-need approaches that seamlessly integrate with existing clinical workflows, ensuring increased accessibility and affordability. This opportunity encourages the creation of solutions tailored to low-resource settings, such as leveraging telehealth technologies. | United States small business concerns (SBCs) |
NIH | |
| Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) - Grants are available to accelerate the development of Digital Therapeutics to treat Substance Use Disorders. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NIDA | |
| Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) - This funding opportunity aims to accelerate the integration of evidence-based cancer control interventions for People Living with HIV (PLWH) in Low- and Middle-Income Countries (LMICs) by leveraging existing HIV treatment and prevention infrastructure. The NOFO is seeking applications that will identify and address barriers to the adoption, integration, and sustainability of evidence-based cancer control interventions, with a focus on generating data in LMICs that can inform effective implementation worldwide. Proposals may include exploring strategies to integrate telehealth/telemedicine interventions for delivering evidence-based cancer control. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NIH |
Expiring in 6 months or more
| Title | Eligibility | Deadline | Learn More |
|---|---|---|---|
| Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders - This funding opportunity supports applicants in researching new ways to offer remotely-delivered substance use disorder (SUD) treatments to patients, specifically those living in rural or underserved communities. Research is also needed to determine the effectiveness of using telemedicine to conduct SUD treatment, so that the demand for in-person clinical visits can be reduced. | U.S. organizations, both private and public |
NIDA | |
| Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) - The goal of the Support of Research Excellence (SuRE) program is to support research capacity building at institutions that enroll significant numbers of students from backgrounds nationally underrepresented in biomedical research. Key areas of focus include telemedicine and research that builds the scientific foundation for nursing practice and policy across clinical and community settings and more. | U.S. public and private higher education institutions |
NIH | |
| Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) - This funding opportunity announcement support the identification of shared mechanisms and development of innovative interventions (including mHealth technologies) to address multimorbidity or multiple chronic conditions and its consequences. | U.S. organizations, both private and public |
ODP | |
| Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) - This funding opportunity announcement invites applications that seek to improve the availability, quality, and utility of data and measures that capture multimorbidity or multiple chronic conditions and the methods for analyzing multimorbidity data. Development or refinement of biosensor/mHealth measurement approaches and analysis of biosensor/mHealth data is encouraged. | U.S. organizations, both private and public |
ODP | |
| Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) - The goal of this funding opportunity is to support research that concentrates on enhancing the safety of diagnostic practices in diverse ambulatory care settings which range from primary care to telemedicine. AHRQ intends to offer assistance to experiment and assess primary care initiatives and improve the quality and safety of diagnostic procedures. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
AHRQ | |
| HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3 - Clinical Trial Optional) - The COVID-19 pandemic has accelerated the adoption of telehealth and wearable device technology in clinical trials, highlighting the pressing need for more reliable and comprehensive patient outcome measurements in pain therapy research. This funding opportunity seeks to support the development and validation of real-world digital endpoints derived from remote and wearable devices, with a specific focus on monitoring pain experiences, their evolution, response to interventions, and impact on quality of life. | U.S. organizations, both private and public |
NIH | |
| Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required) - This funding opportunity seeks to support clinical trials to establish the effectiveness of interventions and test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. Additionally, this effort supports clinical trials designed to test the therapeutic value of treatment and preventive interventions for which there is already evidence of efficacy, for use in community and practice settings. Applications might include research to evaluate the effectiveness or increase the clinical impact of pharmacologic, somatic, psychosocial (e.g., psychotherapeutic, behavioral), device-based, rehabilitative and combination interventions to prevent or treat mental illness through sustainable means such as telehealth. | U.S. organizations, both private and public |
NIH | |
| Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) - The purpose of this funding opportunity announcement is to encourage pilot research consistent with NIMH's priorities. Applications of technology (digital health or mhealth approaches) are considered. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NIMH | |
| Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) - The purpose of this funding opportunity is to research the effectiveness of therapy and service delivery during the post-acute phase management of mental health conditions. Relevant research topics include maintenance therapies that promote ongoing monitoring, delivered via telehealth or in-person, as well as technology-assisted monitoring that can detect clinical deteriorations. | U.S. organizations, both private and public |
NIH | |
| Notice of Special Interest (NOSI): Telehealth in Cancer Care - National Cancer Institute encourages research on underserved populations with worse cancer outcomes compared to the general population. | U.S. organizations, both private and public |
NIH/NCI | |
| Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research - This Notice of Special Interest (NOSI) encourages grant applications that focus on evaluating the utility and validity of digital health and artificial intelligence tools and technologies in research. | U.S. organizations, both private and public |
NIH | |
| Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) - This funding opportunity supports pilot projects to evaluate the effectiveness of therapeutic and service delivery interventions (e.g. telehealth) for the post-acute management of mental health conditions. | U.S. organizations, both private and public |
NIH | |
| Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) - This grant provides funding to further develop affordable medical technologies, such as telehealth, that will help reduce disparities in access to healthcare and health outcomes among disadvantaged groups. The applicant should aim to address one of the following categories that can impact healthcare disparities: physical, knowledge, infrastructure, economic, and/or cultural. | U.S. organizations, both private and public |
NIH | |
| Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) - The purpose of this funding opportunity announcement is to support research that will advance the measurement and methodology of complex constructs relevant to minority health and health disparities. Access to telehealth technology and broadband access are topics of interest. | U.S. organizations, both private and public |
NIMHD | |
| Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) - This funding opportunity announcement encourages formative research, intervention development, and pilot-testing of interventions for people who use drugs that target HIV prevention, treatment or services research. This includes studies using novel eHealth or mHealth approaches to recruit, enroll, and retain members of key populations. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NIDA | |
| Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) - This funding opportunity encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applicants to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. Additionally, it is designed to encourage research and increase infrastructure support of clinical trials for co-occurring conditions in individuals with Down syndrome. This includes research on the development of technologies, screening access and management through new delivery systems such as telehealth. | U.S. organizations, both private and public |
NIH | |
| Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) - This funding opportunity seeks applications for research projects that evaluate the effectiveness of digital healthcare interventions in improving the quality of healthcare services delivered through digital solutions such as telehealth. Applicants are expected to evaluate the digital healthcare intervention and the problem it may address, as well as how the intervention will be implemented into the clinical workflow, measure performance, reduce health disparities, and evaluate reliability, validity, and usability for all users of the telehealth system. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
AHRQ | |
| Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) - This initiative will support innovative research to develop multi-level/multi-component strategies to effectively adapt and implement comprehensive clinical care for individuals with Type 2 diabetes mellitus from populations with health disparities. Special interests include telehealth effectiveness on the continuity of diabetes care during public health emergencies. | U.S. organizations, both private and public |
NIMHD | |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) - The purpose of this funding opportunity announcement is to encourage applications to pursue invasive neural recording studies focused on mental health-relevant questions. Development of novel tools/methods to enable relevant mental health studies is encouraged. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NIMH | |
| Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders - National Institute on Drug Abuse (NIDA) research funding to explore and develop telehealth methods and strategies for diagnosis, prevention, and treatment for individuals living with HIV and substance use disorder. | U.S. organizations, both private and public |
NIH/NIDA | |
| Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) - Grants are available to support innovative, collaborative, and multi-disciplinary research designed to study the effective adaptation, integration, and implementation of recommended guidelines of care of persons with multiple chronic conditions from populations that experience health disparities. The role of health information technology, including telehealth, in proactive health care delivery is of interest. | U.S. organizations, both private and public |
NIMHD | |
| Clinical and Translational Science Award (UM1 Clinical Trial Optional) - Applications are being accepted for Clinical and Translational Science Award Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NCATS | |
| Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed) - Funding supports the development and demonstration of capabilities, research platforms and resources to address gaps and roadblocks in clinical and translational science including telehealth. | U.S. organizations, both private and public |
NCATS | |
| Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) - This funding opportunity supports eligible institutions to enhance predoctoral research training of individuals seeking a PhD or an equivalent research health professional degree. To achieve this, programs are encouraged to build on the local strengths and demonstrated translational innovations, interventions and behavioral modifications aimed at improving knowledge in areas such as health disparities, telehealth and telemedicine, rural health, community engagement, bioinformatics, dissemination and implementation. | U.S. organizations, both private and public |
NIH | |
| Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) - The goal of this funding opportunity is to encourage institutions to propose creative and innovative institutional research career development programs designed to prepare an outstanding heterogeneous pool of promising later stage postdoctoral fellows and junior faculty scholars in clinical and translational science (including telehealth and telemedicine) who have made a commitment to independent research careers (i.e., tenure-track or equivalent faculty positions), and to facilitate their timely transition to more advanced support. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NIH | |
| Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) - The National Cancer Institute (NCI) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, including telehealth and telemedicine. | U.S. organizations, both private and public |
NIH | |
| Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional) - This funding opportunity focuses on accelerating the development and validation of predictive tools and biomarkers in order to inform treatment selection for depression. | U.S. organizations, both private and public |
NIH | |
| Digital Technology for Early Detection and Monitoring of Alzheimer’s Disease and Related Dementias - This notice of special interest (NOSI) funding opportunity aims to promote research on utilizing digital signals and data as a form of digital phenotyping. The purpose of this research is to identify and flag individuals at risk of Alzheimer’s disease and Alzheimer’s disease-related dementias about early stages before cognitive symptoms are detected. Promising areas of research include but are not limited to the use of telehealth and digital health technology. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
NIA | |
| NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional) - As part of the National Institute on Drug Abuse (NIDA)’s Racial Equity Initiative (REI), this funding opportunity focuses on supporting pilot or feasibility research on structural factors, organizational practices, policies, and other social, cultural, and contextual influences that lead to inequities at the intersection of HIV and substance use among underserved racial and/or ethnic minority populations affected by persistent HIV disparities. | U.S. organizations, both private and public |
NIDA | |
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) - This funding opportunity supports research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies, including telemedicine. | U.S. organizations, both private and public |
NIH | |
| Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) - This is a funding opportunity supporting research that investigates the effectiveness of school-based health centers as a health services care delivery model to address the needs of school-aged children from populations with health disparities. Areas of special interest include telehealth. | U.S. organizations, both private and public |
NIMHD | |
| Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) - This funding opportunity supports innovative multi-disciplinary and multi-level research designed to understand how optimizing patient-clinician communications and relationships affect health care outcomes in populations with health care disparities. This includes studies that evaluate the effects of telehealth communication. | U.S. organizations, both private and public |
NIMHD | |
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) - This funding opportunity seeks to support the initiation and building of the next generation of population-based cancer epidemiology cohorts to address specific knowledge gaps in cancer etiology and survivorship. Areas of feasible study include test measures related to healthcare delivery such as telehealth. | U.S. organizations, both private and public |
NIH | |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) - This funding opportunity is for groundbreaking research projects aimed at testing strategies to enhance the reach, efficiency, effectiveness, and quality of digital mental health interventions. | U.S. organizations, both private and public |
NIH | |
| AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Scientist Career Development Award (K08) - The AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Scientist Career Development Award (K08) provides financial and research support for individuals with clinical doctoral degrees to engage in mentored research and didactic study in patient-centered outcomes research, including the development of telehealth solutions and other digital health care tools. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
AHRQ | |
| Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) - This funding opportunity supports research that examines the impact of leveraging health information technology (health IT) to reduce disparities in access to and utilization of health care services, patient-clinician communication, and health outcomes for populations that experience health disparities in the U.S. Special areas of interest include the evaluation of telehealth policies on access to care, the impact of telehealth care delivery models on quality of care and interventions to address the challenges that can impact telehealth engagement and adherence to treatment plans. | U.S. organizations, both private and public |
NIH | |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) - The purpose of this funding opportunity is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Applications that focus on re-implementation of evidence-based health services (e.g., telehealth and telemedicine) that may have dropped off amidst the ongoing COVID-19 pandemic are encouraged. | U.S. organizations, both private and public |
NIH | |
| Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) - Through this funding opportunity, the National Cancer Institute intends to accelerate the development of evidence-based cancer-related interventions that reflect the diversity of people, places, contexts, and settings in the United States. This funding opportunity will support research that tests the impact of cancer-related interventions on cancer-related outcomes across the cancer control continuum using a pragmatic trial study design. Interventions that leverage novel delivery modalities such as telehealth and interventions that can be delivered for populations in diverse locations such as rural areas are key areas of focus. | U.S. organizations, both private and public |
NIH | |
| Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) - This funding opportunity is aimed at supporting small business concerns (SBCs) in the development of technologies to address health-related social needs (HRSN) impacting substance use disorders (SUD) other than alcohol use disorder. | United States small business concerns (SBCs) |
NIH | |
| Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities - This Notice of Special Interest seeks to support research on the real-world effectiveness of telehealth collaboration among health care providers, specifically provider-to-provider telehealth, to improve access to critical health expertise in remote communities. The research aims to advance health equity and access to care, investigate the effectiveness of provider-to-provider telehealth in managing rural populations' health, and develop implementation strategies in settings where clinical effectiveness is established. | U.S. organizations, both private and public |
NIH | |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) - This opportunity works to address barriers to cancer screening and preventive services in populations experiencing health disparities. Projects should include barriers and facilitators at various levels, such as patient, clinician, health care setting, and neighborhood/community, and may include telehealth implementation. | U.S. organizations, both private and public |
NIH | |
| Virtual Living Room - Using Technology to Address the Critical Healthcare Needs of Veterans in Rural Areas - This program supports organizations who can offer a comfortable, safe space to help veterans use VA telehealth services. | Applicants must be members of NTCA: The Rural Broadband Association (https://www.ntca.org/) and their community over an hour away from a VA Clinic or hospital |
Ongoing | Veterans Affairs |
| Community Facilities Direct Loan & Grant Program - This program provides funding to develop community facilities in rural areas. Funds may be used to construct or improve facilities and includes utility services like telemedicine and distance learning equipment. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
Ongoing | USDA |
| Family Planning Telehealth Infrastructure Enhancement and Expansion Grants - This program provides one-time funding to expand and enhance the telehealth infrastructure and capacity of their service delivery networks. | Public or private nonprofits, including tribal, faith-based, and community-based organizations |
Ongoing | HHS |
Important information
Providers who receive federal funds must provide an equal opportunity to participate in, and benefit from, their programs and services by all individuals regardless of race, color, national origin (including language spoken), disability, age, and sex (including sexual orientation and gender identity).
Disability access
The Americans with Disabilities Act of 1990 (ADA) and Section 504 of the Rehabilitation Act of 1973 (Section 504) are federal civil rights law that prohibit discrimination against individuals with disabilities. These statutes require covered health programs and medical care providers to make their services, including telehealth services, available in an accessible manner. For more information on how to ensure that your programs and services are accessible to people with disabilities, please visit the HHS Office for Civil Rights webpage on Disability Access and ADA.gov.
Language access
Title VI of the Civil Rights Act of 1964 requires recipients of federal financial assistance to take reasonable steps to make their programs and services, including telehealth services, accessible by individuals who are limited English proficient (LEP). For more information on how to ensure that your programs and services are accessible to people who are LEP, please visit the HHS Office for Civil Rights webpage on Language Access and LEP.gov.